Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
Incyte Corporation
BeOne Medicines
Pfizer
Eilean Therapeutics
Eilean Therapeutics
Novartis
Chordia Therapeutics, Inc.
GluBio Therapeutics Inc.
Beijing InnoCare Pharma Tech Co., Ltd.
Janssen Research & Development, LLC
Beijing Biotech
Karyopharm Therapeutics Inc
TScan Therapeutics, Inc.
Bristol-Myers Squibb
Seagen Inc.
Novartis
Blueprint Medicines Corporation
Novartis
Changchun GeneScience Pharmaceutical Co., Ltd.
Incyte Corporation
Incyte Corporation
Taiho Oncology, Inc.
Novartis
Novartis
Merck Sharp & Dohme LLC
Incyte Corporation
Enliven Therapeutics
Blueprint Medicines Corporation
Novartis
Prelude Therapeutics
iOnctura
Inmune Bio, Inc.
Servier
Novartis
Italfarmaco
Remedy Plan, Inc.
Sumitomo Pharma America, Inc.
Incyte Corporation
Shenzhen TargetRx Co., Ltd.
AbbVie
Novartis
Curis, Inc.
CareDx
Novartis
Shattuck Labs, Inc.
AstraZeneca
Takeda
Novartis
Incyte Corporation